Cargando…
Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192124/ https://www.ncbi.nlm.nih.gov/pubmed/35717374 http://dx.doi.org/10.1016/j.transci.2022.103490 |
| _version_ | 1784726168118755328 |
|---|---|
| author | Seghatchian, Jerard |
| author_facet | Seghatchian, Jerard |
| author_sort | Seghatchian, Jerard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9192124 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91921242022-06-14 Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes Seghatchian, Jerard Transfus Apher Sci Article Published by Elsevier Ltd. 2022-08 2022-06-14 /pmc/articles/PMC9192124/ /pubmed/35717374 http://dx.doi.org/10.1016/j.transci.2022.103490 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Seghatchian, Jerard Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes |
| title | Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes |
| title_full | Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes |
| title_fullStr | Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes |
| title_full_unstemmed | Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes |
| title_short | Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes |
| title_sort | editorial: time to explore the missing links: the cross-talk between covid infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “omicron ghosts” and insights from car-t cell therapy pointing toward better clinical outcomes |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192124/ https://www.ncbi.nlm.nih.gov/pubmed/35717374 http://dx.doi.org/10.1016/j.transci.2022.103490 |
| work_keys_str_mv | AT seghatchianjerard editorialtimetoexplorethemissinglinksthecrosstalkbetweencovidinfectionandcancercellslingeringquestionsonthelongitudinalefficacyofthefrontlineimmunotherapiesagainstunpredictableomicronghostsandinsightsfromcartcelltherapypointingtowardbetterclinicaloutcomes |